SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-059538
Filing Date
2019-11-04
Accepted
2019-11-04 16:36:37
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919613-1_10q.htm 10-Q 512106
2 EXHIBIT 31.1 tm19196131_ex31-1.htm EX-31.1 11005
3 EXHIBIT 32.1 tm19196131_ex32-1.htm EX-32.1 4755
4 GRAPHIC tm1919613-1_10qimg001.jpg GRAPHIC 167114
  Complete submission text file 0001104659-19-059538.txt   5573312

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT syn-20190930.xml EX-101.INS 1536786
6 XBRL TAXONOMY EXTENSION SCHEMA syn-20190930.xsd EX-101.SCH 42800
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20190930_cal.xml EX-101.CAL 43956
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20190930_def.xml EX-101.DEF 183938
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20190930_lab.xml EX-101.LAB 321828
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20190930_pre.xml EX-101.PRE 301079
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 191190343
SIC: 2834 Pharmaceutical Preparations